Ad
related to: moderna vaccine update
Search results
FDA approves Moderna’s mRNA RSV vaccine
The Hill via Yahoo News· 2 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV the second disease...
Moderna just got FDA approval for its RSV vaccine — only its second product on the market
Quartz· 2 days agoThe Food and Drug Administration on Friday approved Moderna’s mRNA-based respiratory syncytial virus...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks· 5 days agoShares of Moderna (MRNA) are being driven by encouraging pipeline updates and plans for potential product launches.
Moderna’s vaccine for RSV gets FDA approval for people 60 and older - The Boston Globe
The Boston Globe· 2 days agoModerna said Friday that US drug regulators have approved its second product, a vaccine for...
Why Moderna Stock Is Sinking This Week
Motley Fool via Yahoo Finance· 3 days agoShould you invest $1,000 in Moderna right now? Before you buy stock in Moderna, consider this: The Motley Fool...Advisor provides investors with an...
US nears deal to fund Moderna's bird flu vaccine trial, FT reports
Colorado Springs Gazette· 3 days agoModerna told Reuters it was in discussions with the government on advancing its vaccine candidate,...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 3 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
Moderna’s RSV Shot Wins FDA Approval for Use in Older Adults
Bloomberg· 2 days agoModerna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 4 days agoThe stock was down 5.5% Wednesday morning, bringing the stocks losses to 13% since the market closed...
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 7 days agoModerna's mRNA vaccine platform proved its value in the coronavirus market. The company has many...